Literature DB >> 8864208

The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study.

C A Latkin1, W Mandell, D Vlahov, M Oziemkowska, D D Celentano.   

Abstract

Social influence processes have been found to affect numerous drug and health-related behaviors. We postulated that by using a network-oriented intervention it may be possible to capitalize on social influence processes to reduce human immunodeficiency virus (HIV) risk behaviors. The present study used an experimental study design for delivering a psychoeducational acquired immunodeficiency syndrome (AIDS) preventive intervention to injection drug sharing networks. Participants were recruited from the ALIVE study, an epidemiological study in Baltimore. In the present paper we examine the self-reported behavioral outcomes of 117 injection drug users 18 months after the baseline interview. HIV seronegative experimental participants reported significantly less frequent needle sharing and less injecting of heroin and cocaine than controls. In multiple logistic regression models of HIV seronegative participants, there was a significant negative association between assignment to the experimental group and the HIV-related behaviors of needle sharing and sharing of cookers in the prior 6 months; controls were 2.8 times more likely than experimentals to report needle sharing and were 2.7 times more likely to report sharing cookers. The results of this 18-month follow-up suggest that among injection drug users network-oriented interventions may be a promising approach to HIV prevention.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864208     DOI: 10.1007/bf02512026

Source DB:  PubMed          Journal:  Am J Community Psychol        ISSN: 0091-0562


  39 in total

1.  HIV prevention research: accomplishments and challenges for the third decade of AIDS.

Authors:  J D Auerbach; T J Coates
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 2.  Social networks, risk-potential networks, health, and disease.

Authors:  S R Friedman; S Aral
Journal:  J Urban Health       Date:  2001-09       Impact factor: 3.671

3.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

Review 4.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

5.  A social network profile and HIV risk among men on methadone: do social networks matter?

Authors:  Nabila El-Bassel; Louisa Gilbert; Elwin Wu; Mingway Chang
Journal:  J Urban Health       Date:  2006-07       Impact factor: 3.671

Review 6.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

7.  PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men.

Authors:  Lindsay E Young; Phil Schumm; Leigh Alon; Alida Bouris; Matthew Ferreira; Brandon Hill; Aditya S Khanna; Thomas W Valente; John A Schneider
Journal:  Clin Trials       Date:  2017-09-01       Impact factor: 2.486

8.  Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.

Authors:  C A Latkin
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 9.  The network approach and interventions to prevent HIV among injection drug users.

Authors:  A Neaigus
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.